We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Argent Biopharma Limited | LSE:RGT | London | Ordinary Share | AU0000326647 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 21.00 | 20.00 | 22.00 | 21.00 | 21.00 | 21.00 | 7,884 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/9/2011 18:57 | Sadly shareholders stuffed again. | danielmiller1 | |
13/9/2011 07:13 | China Alzheimers Seattle firms plan senior housing for China's booming elderly population Serena Xie is sure there's a market in China for American-style, for-profit senior-care facilities. Her own family underscores the demographic and social changes creating the need. | share_shark | |
07/9/2011 20:48 | For those shareholders who think this is Regen Ltd only forum please go to | genises | |
06/9/2011 08:10 | FAO Runtus. Hello there and I know you were very interested in this particular field. | share_shark | |
06/9/2011 06:52 | open attachment. Does anyone know if this PRP is CLN???? | impala391 | |
25/8/2011 11:48 | Well, it was re more orders rather than more products SS, just to check, so you know that those deals would require more product to be ordered rather than them having already ordered it? | the_doctor | |
25/8/2011 11:41 | Asmod. What are you talking about again?. | share_shark | |
25/8/2011 11:04 | What are you on about, Share_Shark? Who has been carving you up now? | asmodeus | |
25/8/2011 10:53 | Yes to your last question on "more products " Doc. | share_shark | |
25/8/2011 10:52 | 'September should see Iran and the UAE sign distribution deals, and Argentina-Uruguay-Pa good to hear dante would these involve more product orders, or do they have some already? | the_doctor | |
25/8/2011 10:51 | I have spent countless hours, since RGT became Newco, spreading the gospel around the USA and Poland(where I have contacts). Life is so very funny isnt it?. | share_shark | |
25/8/2011 10:33 | tThanks for that Dante and can confirm what you have posted from my own DYOR(Tim). SS | share_shark | |
25/8/2011 10:31 | Very interesting. Thanks for that Share Shark. I just bought yet another box of Cognase and can confirm that sales are going well in Cyprus. The plan remains for Golgi to switch to the new orange-flavoured tablets that ReGen itself will be producing (and selling at higher profit margins) and it may even become a regional supplier to other distributors. September should see Iran and the UAE sign distribution deals, and Argentina-Uruguay-Pa To quote Gen, onwards and upwards... | dante17 | |
25/8/2011 07:13 | Milk, Glorious Milk Aug 24, 2011 Melanie Hundley Unlocking the secrets of milk - Ambro2011: New research heralds the amazing medical benefits of mammalian milk. It seems the most we hear about milk these days is related to lactose intolerance, allergies, or contamination. And these certainly are serious health conditions. However, a new research study published in Food Reviews International offers renewed insight and celebration for the redeeming qualities of nature's white nectar. It is through ongoing research on milk that breakthroughs and treatments of milk-related conditions plus a host of other ailments are also furthered. A team of researchers from the University of Warmia and Mazury in Poland, Darewicz, B., Dziuba, Minkiewicz, and J. Dziuba, considered the "preventive potential of millk and colostrum proteins and protein fragments." This article is a review of their upcoming October 2011 published work. A read of the full research piece is always recommended to complement this review. Milk, Glorious Milk Darewicz et al. introduced their research study by singing the praises of milk including: Ads by Google Fibromyalgia Treatment Eliminate the Pain, Proven Results Affordable Care, We can help! www.painfromfibromya Gluten-free products Lactofree offers a range of gluten free products. All 100% real dairy www.lactofree.co.uk How milk is chock-full of so many key proteins, fats, minerals, and a list of vitamins, e.g., A & B; How first milk (colostrum) serves up unique and precious components for newborns, e.g., immunoglobulins, extra vitamins and extra calcium, etc.; and How research has explored the recombinant proteins, "functional attributes, nutritional value, and allergizing properties" of this amazing natural food. Speaking of proteins, Darewicz et al. provided additional insight on the increasing interest in "biologically active proteins and peptides" in medicine and food sources. Health courses in school may have provided some instruction on the nature of proteins, e.g., proteins are the building blocks of amino acids and are required for energy in living cells. Many students' understanding of amino acids may have ended there. However, as Darewicz et al. point out, the understanding of milk protein chemistry has exploded in a good way in more recent years. Researchers have taken proteins to task and have reportedly determined a vast world of "biologically active peptides" and enzymes are at play below the amino acid level. And researchers appear to agree, milk contains a plethora of these amazing components. Besides enabling the fermentation processes involved in making cheese and other dairy products, milk peptides are believed to hold secrets of anti-hypertensive, anti-microbial functions, and the buzz word of the millennium, anti-oxidants. Darewicz et al. do advise that the human digestion process may wreak havoc on some bioactive peptides. The soup of digestive enzymes and acids in most stomachs appears to be pretty tough on milk peptides, and there are other chemical properties at play in the survival and transport of the digested milk components. The researchers provide an excellent overview of some testing on "casein and whey proteins" that followed various peptides into the cellular levels. Read This Next Ways to Get Calcium on a GFCF Diet Raw Milk - Pure Probiotics or Pasteurization? No Relief Likely for New Zealand Domestic Milk Price Computers and Milk Research Data Darewicz et al. inform readers about the relatively new area of science called "bioinformatics." While lab researchers have been using statistical analysis to prove their hypotheses for generations, the computer age has given way to mankind's ability to infinitely slice and dice test data. Such was the case in the research highlighted in the University of Warmia and Mazury study. Protein "data" was interrogated to help predict various attributes of milk peptides. By testing and cataloging the results, the medicinal properties of peptides and even fragments of peptides may be identified for further analysis. Darewicz et al. point out that through these focused studies various anti-thrombotic actions and celiac disease studies from various milk protein fractions have been discovered. Milk Components and Related Research Here is a partial list of milk components released by various biochemical and enzymatic action and the potential treatment areas mentioned by the Polish researchers: Caseins (in addition to those listed above, nervous system opioids, other immunity modulators); Whey proteins (anti-hypertensive, anti-bacterial, anti-cancer, opioids, stress reduction, and anti-viral); Lactoferrin (anti-microbial, anti-fungal, anti-viral, anti-cancer); Lysozyme (anti-microbial, anti-caries, anti-bacterial, anti-tumor, and food preservation); Lactoperoxidase (anti-bacterial, anti-inflammatory); Glycomacropeptide (anti-bacterial, caries prevention, opioids, anti-thrombotic, enhanced "adsorption of zinc, calcium, and iron," immune responsiveness, and weight control; and Protein-Rich Peptides (anti-bacterial, anti-cancer, anti-fungal, anti-viral, and in the case of colostrinin, enhances certain immunity aspects and has been studied in anti-Alzheimer applications. Conclusion Darewicz et al. have definitely reinvigorated my respect for natural milk. While many of the treatments cited may also require special processing or restricted processing in order to glean the desired effects, I agree with this team that a "new range of applications for milk and colostrum proteins and peptides" are poised to reveal new wonders. Special thanks to Dr. Malgozata Darewicz, Professor and Chair at the University of Warmia and Mazury, for sharing additional insight with me on the team's research efforts. Disclaimer: This is an editorial review only, written by a non-medical author, and is subject to change or update. The information and links contained in this article are for educational purposes only to support further inquiry and should not be used for diagnosis or to guide treatment. Any reader who is concerned about his or her health should contact a licensed medical doctor for advice. While every effort is made to ensure accuracy, readers should always refer to the original cited sources for verification and/or any interpretation of source material. Author assumes no liability for content, errors, and/or omissions. Sources Cornell University. Milk protein. Retrieved August 24, 2011, from education website. Darewicz, M., Dziuba, B., Minkiewicz, P., & Dziuba, J. (2011). The Preventive Potential of Milk and Colostrum Proteins and Protein Fragments. Food Reviews International, 27(4), 357-388. Retrieved August 24, 2011, from EBSCOhost online database. DOI:10.1080/87559129 Farlex, Inc. (2011). Colostrum. Retrieved August 24, 2011, from thefreedictionary.co Farlex, Inc. (2011). Recombinant Protein. Retrieved August 24, 2011, from thefreedictionary.co Foster, R. (2004). Colostrum and colostrum derivative research. Receptol Research. Retrieved August 24, 2011, from organization website. MedicineNet.com. (2011). Antihypertensive. Retrieved August 24, 2011, from corporate website. MedicineNet.com. (2011). Antimicrobial. Retrieved August 24, 2011, from corporate website. MedicineNet.com. (2011). Blood Clots [antithrombotic]. Retrieved August 24, 2011, from corporate website. MedicineNet.com. (2011). Celiac Disease (Gluten Enteropathy). Retrieved August 24, 2011, from corporate website. MedicineNet.com. (2011). Definition of Antioxidant. Retrieved August 24, 2011, from corporate website. MedicineNet.com. (2011). Definition of Antiviral. Retrieved August 24, 2011, from corporate website. MedicineNet.com. (2011). Definition of Caries. Retrieved August 24, 2011, from corporate website. MedicineNet.com. (2011). Definition of Enzyme [Enzymatic]. Retrieved August 24, 2011, from corporate website. MedicineNet.com. (2011). Definition of Opioid. Retrieved August 24, 2011, from corporate website. MedicineNet.com. (2011). Lactose Intolerance. Retrieved August 24, 2011, from corporate website. Merriam-Webster, Inc. (2011). Peptide. Retrieved August 24, 2011, from corporate website. National Center for Biotechnology Information. (2004). A Science Primer: Bioinformatics. Retrieved August 24, 2011, from government website. Schwarze, S., Ho, Al, Vocero-Akbani, A., and Dowdy, S. (1999, September 3). In vivo protein transduction: delivery of a biologically active protein into the mouse. Science, Volume 285, No. 5433, 1569-1572. Retrieved August 24, 2011, from Science Magazine online. DOI: 10.1126 Read more at Suite101: Milk, Glorious Milk | Suite101.com | share_shark | |
24/8/2011 11:02 | 'Apparently Tim says that Met have their strategic reveiw on the 8th.September with Amway/Alticor.' Thanks. That is likely to be critical IMO | the_doctor | |
24/8/2011 07:24 | Alzheimer's disease health centre.. £800 million for groundbreaking medical research Record government funding to be spent on research into diseases like Alzheimer's, cancer and diabetes. By Siobhan Harris WebMD Health News Reviewed by Dr Farah Ahmed 19th August 2011 - Medical research has been given an £800 million pound boost by the Government. The money will be spent over five years allowing hospitals and universities to develop new medicines and treatments to try to ensure the UK remains a world leader in health research. The money is the UK's largest ever investment in early stage health research. It will fund advances in diagnosis, prevention and treatment which will ultimately benefit patients with diseases like cancer, diabetes and heart disease. Sharing the cash The research will be carried out through NHS and university partnerships managed by the National Institute for Health Research (NIHR). Those in line for the extra funding include Imperial College London and Imperial College NHS Healthcare Trust for their work in genetics, bioengineering and cancer. Moorfield's eye hospital and its partner University College London also get a share of the cash. Four research units specialising in dementia research will share £18 million pounds. Investing for the future Announcing the money, Prime Minister David Cameron said in a statement: "A strong competitive science and research base is a crucial part of securing a sustainable economic growth and creating jobs for the future, and we have some of the best scientists and facilities in the world. This investment will help ensure we continue to be at the cutting edge." Health Secretary Andrew Lansley added: "We want to ensure we can give NHS patients the very best possible treatments and health outcomes. To do this we need to give British scientists the means and the tools to develop ground breaking world class health research." He went on to say, "Dementia research features strongly in the programme of funding. Dementia is one of the most important issues that we face as our population ages. " The Alzheimer's Society has welcomed the boost. A spokesperson said in an emailed statement: "It is fabulous news that dementia research is finally being taken seriously and beginning to be treated as the priority it should be. The funding is a very significant first step on the road to bringing dementia in line with other conditions such as cancer, which receives eight times more government funding." -------------------- Good post by Genises re Metagenics. Apparently Tim says that Met have their strategic reveiw on the 8th.September with Amway/Alticor. Sk moving ahead too. | share_shark | |
27/7/2011 23:39 | i see ss still posting a load of old rubbish again not just with this thread might i add.......no offence meant ss but i do just skip your posts now as they are too long and not connected most of the time with the issues. | doorway | |
20/7/2011 11:27 | This is for the MEN/WOMEN shareholders and NOT for the boys...............s article.php?newsID=1 | share_shark | |
19/7/2011 23:33 | ...zzzzzzzzzzzzzzzzz | lean5gb | |
18/7/2011 11:59 | 'If Metagenics is not interested in this news then I will have to eat my hat' eh?? Want some ketchup with that s_s? I honestly dont see it making any difference whatsoever | the_doctor | |
18/7/2011 10:47 | If Metagenics is not interested in this news then I will have to eat my hat !. | share_shark | |
18/7/2011 07:06 | Thanks guys. Zolp and Memoryaid ?. | share_shark |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions